Skip to search formSkip to main contentSkip to account menu

Zeldox

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Preparation and evaluation of ziprasidone–phospholipid complex from sustained‐release pellet formulation with enhanced bioavailability and no food effect
The purpose of this work was to develop ziprasidone–phospholipid complex (ZIP‐PLC) in sustained‐release pellets to enhance the… 
2015
2015
Controlled release of ziprasidone solid dispersion systems from osmotic pump tablets with enhanced bioavailability in the fasted state
Abstract Objective: The purpose of this work was to develop a controlled release of ziprasidone with no food effect by the… 
2015
2015
Formulation development and systematic optimization of stabilized ziprasidone hydrochloride capsules devoid of any food effect
Abstract Context and objective: The objective of the study was to develop a stable capsule formulation of ziprasidone… 
2010
2010
Pharma News
Ziprasidon (Zeldox®) ist, neben der bekannten Zulassung für Schizophrenie bei Erwachsenen, auch zur Behandlung von manischen oder… 
2009
2009
How to establish what medication is responsible for side effects in a patient with polypragmasy
Treatment of psychosis calls for use of antipsychotics, often along with antidepressants, mood stabilizers, anxiolitycs… 
2004
2004
[Misdiagnosed PTSD and zeldox pharmacotherapy in case of a political prisoner].
Treatment of survivors of political terror is an emerging and difficult field. Reports on posttraumatic stress disorder (PTSD) in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)